FDA Approved: FENOFIBRATE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application for fenofibrate from Apotex Corp., resulting in a label change for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• FENOFIBRATE (Fenofibrate)

Snippet

SUPPL AP for FENOFIBRATE (FENOFIBRATE)